Bigham, A., Zarepour, A., Khosravi, A., Iravani, S., & Zarrabi, A. (2024). Sustainable nanomaterials for precision medicine in cancer therapy. Materials Today Sustainability, 100865. https://doi.org/10.1016/j.mtsust.2024.100865
Brown, D. G., (2024) A Drug Discovery Perspective on FDA Expedited Development and Incentive Programs. J. Med. Chem. 67, 1690–1700. https://doi.org/10.2174/1566524023666230622151034
Sangwan, K., Sharma, V., & Goyal, P. K. (2024). Pharmacological profile of novel anti-cancer drugs approved by USFDA in 2022: A review. Current Molecular Medicine, 24(6), 734–750.
Kishore, S., Kumar, S. A., Roy, T., Bhardwaj, A., & Malik, S. (2022). Nanoemulsion Formulations in Targeted Delivery of Cancer Therapeutics. Advancements in Controlled Drug Delivery Systems (pp. 44–72). IGI Global. https://doi.org/10.4018/978-1-7998-8908-3.ch003
Hussain, Y., Khan, H., Ahmad, I., Efferth, T., & Alam, W. (2022). Nanoscale delivery of phytochemicals targeting CRISPR/Cas9 for cancer therapy. Phytomedicine, 94, 153830.
Article CAS PubMed Google Scholar
Kashyap, B. K., Singh, V. V., Solanki, M. K., Kumar, A., Ruokolainen, J., & Kesari, K. K. (2023). Smart nanomaterials in cancer theranostics: challenges and opportunities. ACS omega, 8(16), 14290–14320.
Article CAS PubMed PubMed Central Google Scholar
Patil, S., & Chandrasekaran, R. (2020). Biogenic nanoparticles: A comprehensive perspective in synthesis, characterization, application and its challenges. J Genet Eng Biotechnol, 18(1), 1–23.
Malik, S., Jang, W., Kim, J. Y., & Kim, C. (2020). Mechanisms ensuring robust repression of the Drosophila female germline stem cell maintenance factor Nanos via posttranscriptional regulation. The FASEB Journal, 34(9), 11421–11430.
Article CAS PubMed Google Scholar
Wang, S., Cheng, K., Chen, K., Xu, C., Ma, P., Dang, G., Yang, Y., Lei, Q., Huang, H., Yu, Y., & Fang, Y. (2022). Nanoparticle-based medicines in clinical cancer therapy. Nano Today, 45, p101512.
Dhasmana, A., Dobhal, P., Sati, A., Santhanam, A., Preetam, S., Malik, S., Joshi, N., Rustagi, S., & Deshwal, R. K. (2025). Synthesis of fungal polysaccharide-based nanoemulsions for cancer treatment. RSC advances, 15(17), 13300–13312.
Article CAS PubMed PubMed Central Google Scholar
Dhasmana, A., Santhanam, A., Dhasmana, K., Malik, S., & Preetam, S. (2025). Innovative Smart Biosensors for Cancer Theranostics: A New Frontier in Detection, Diagnosis, and Beyond. Cancer Treatment and Research Communications, 43, 100911.
Wang, L., Chen, H., Wang, F., & Zhang, X. (2022). The development of peptide-drug conjugates (PDCs) strategies for paclitaxel. Expert Opinion on Drug Delivery, 19(2), 147–161.
Article CAS PubMed Google Scholar
Elumalai, K., Srinivasan, S., & Shanmugam, A. (2024). Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomedical Technology, 5, 109–122.
Wang, C., & Zhang, S. (2023). Advantages of nanomedicine in cancer therapy: A review. ACS Applied Nano Materials, 6(24), 22594–22610.
Gallego-Jara, J., Lozano-Terol, G., Sola-Martínez, R. A., Cánovas-Díaz, M., & de Diego Puente, T. (2020). A compressive review about taxol®: History and future challenges. Molecules, 25(24), 5986.
Article CAS PubMed PubMed Central Google Scholar
Manikkam, R., Periyasamy, V., & Sabapathy, I. (2023). Repurposing of phytocompounds-derived novel bioactive compounds possessing promising anticancer and cancer therapeutic efficacy through molecular docking, MD simulation, and drug-likeness/ADMET studies. Computational Methods in Drug Discovery and Repurposing for Cancer Therapy (pp. 201–222). Academic. https://doi.org/10.1016/B978-0-443-15280-1.00020-0
Yadav, V., Mittal, L., Paliwal, S., Asthana, S., & Tonk, R. K. (2023). Repurposing of flavonoids as promising phytochemicals for the treatment of lung carcinoma. Drug repurposing for emerging infectious diseases and cancer (pp. 89–110). Springer Nature Singapore. https://doi.org/10.1007/978-981-19-5399-6_6
Kim, J. H., Dareowolabi, B. O., Thiruvengadam, R., & Moon, E. Y. (2024). Application of Nanotechnology and Phytochemicals in Anticancer Therapy. Pharmaceutics, 16(9), p.1169.
Sreelakshmi, S., Vineeth, P. K., Mohanan, A., & Ramesh, N. V. (2021). Ayurvedic bhasma and synthesized nanoparticles: a comparative review. Mater Today: Proc, 46, 3079–3083.
Solanki, R., Jodha, B., Prabina, K. E., Aggarwal, N., & Patel, S. (2022). Recent advances in phytochemical based nano-drug delivery systems to combat breast cancer: A review. Journal of Drug Delivery Science and Technology, 77, 103832.
Bhattacharjee, R., Kumar, L., Mukerjee, N., Anand, U., Dhasmana, A., Preetam, S., Bhaumik, S., Sihi, S., Pal, S., Khare, T., & Chattopadhyay, S. (2022). The emergence of metal oxide nanoparticles (NPs) as a phytomedicine: A two-facet role in plant growth, nano-toxicity and anti-phyto-microbial activity. Biomedicine & Pharmacotherapy, 155, 113658.
Kumar, G., Virmani, T., Sharma, A., & Pathak, K. (2023). Codelivery of phytochemicals with conventional anticancer drugs in form of nanocarriers. Pharmaceutics, 15(3), 889.
Article CAS PubMed PubMed Central Google Scholar
Melim, C., Magalhães, M., Santos, A. C., Campos, E. J., & Cabral, C. (2022). Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade. Expert opinion on drug delivery, 19(2), 179–197.
Article CAS PubMed Google Scholar
Sharma, D., Chelvi, T. P., Kaur, J., Chakravorty, K., De, T. K., Maitra, A., & Ralhan, R. (1996). Novel taxol® formulation: polyvinylpyrrolidone nanoparticle-encapsulated taxol® for drug delivery in cancer therapy. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 8(7–8), 281–286.
Zhu, Z., Li, Y., Li, X., Li, R., Jia, Z., Liu, B., Guo, W., Wu, W., & Jiang, X. (2010). Paclitaxel-loaded poly (N-vinylpyrrolidone)-b-poly (ε-caprolactone) nanoparticles: preparation and antitumor activity in vivo. Journal Of Controlled Release : Official Journal Of The Controlled Release Society, 142(3), 438–446.
Article CAS PubMed Google Scholar
Yuan, H., Guo, H., Luan, X., He, M., Li, F., Burnett, J., Truchan, N., & Sun, D. (2020). Albumin nanoparticle of paclitaxel (Abraxane) decreases while taxol increases breast cancer stem cells in treatment of triple negative breast cancer. Molecular Pharmaceutics, 17(7), 2275–2286.
Article CAS PubMed PubMed Central Google Scholar
Kirtonia, A., Gala, K., Fernandes, S. G., Pandya, G., Pandey, A. K., Sethi, G., Khattar, E., & Garg, M. (2021). Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics. In Seminars in cancer biology (68), 258–278). Academic Press.
Pillai, J., Ray, A., Maan, M., & Dutta, M. (2023). Repurposing drugs targeting metabolic diseases for cancer therapeutics. Drug Discovery Today, 28(9), 103684.
Turabi, K. S., Deshmukh, A., Paul, S., Swami, D., Siddiqui, S., Kumar, U., Naikar, S., Devarajan, S., Basu, S., Paul, M. K., & Aich, J. (2022). Drug repurposing—an emerging strategy in cancer therapeutics. Naunyn-Schmiedeberg’s Archives of Pharmacology, 395(10), 1139–1158.
Article CAS PubMed Google Scholar
Duarte, D., Rêma, A., Amorim, I., & Vale, N. (2022). Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells (Vol. 12, p. 190). Biomolecules. https://doi.org/10.3390/biom12020190
Dhasmana,A., Malik, S., Ranjan, A., Chauhan, A., Tashkandi, H. M., Haque, S., Al-Raddadi, R., Harakeh, S., Zengin, G. (2022). A Bioengineered Quercetin-Loaded 3D Bio-Polymeric Graft for Tissue Regeneration and Repair. Biomedicines, 10(12), p.3157. https://doi.org/10.3390/biomedicines10123157
Mansoori, A., Singh, N., Dubey, S. K., Thakur, T. K., Alkan, N., Das, S. N., & Kumar, A. (2020). Phytochemical characterization and assessment of crude extracts from Lantana camara L. for antioxidant and antimicrobial activity. Frontiers in Agronomy, 2, 582268.
Chen, S., Han, Y., Jian, L., Liao, W., Zhang, Y., & Gao, Y. (2020). Fabrication, characterization, physicochemical stability of zein-chitosan nanocomplex for co-encapsulating curcumin and resveratrol. Carbohydrate polymers, 236, p116090.
Kesarwani, P., Tekade, R. K., & Jain, N. (2011). Spectrophotometric estimation of paclitaxel. Int J Adv Pharm Sci, 2(1), 29–32.
Dhasmana, A., Singh, L., & Malik, S. (2021). Smart Bio-Polymeric Matrix for Accelerated Wound Healing and Tissue Regeneration. Austin J Biomed Eng, 6(1), 1045.
Twilley, D., Thipe, V. C., Kishore, N., Bloebaum, P., Roma-Rodrigues, C., Baptista, P. V., Fernandes, A. R., Selepe, M. A., Langhansova, L., Katti, K., & Lall, N. (2022). Antiproliferative Activity of Buddleja saligna (Willd.) against Melanoma and In Vivo Modulation of Angiogenesis. Pharmaceuticals, 15(12), 1497. https://doi.org/10.3390/ph15121497
Article CAS PubMed PubMed Central Google Scholar
Singh, N., Mansoori, A., Jiwani, G., Solanke, A. U., Thakur, T. K., Kumar, R., & Kumar, A. (2021). Antioxidant and antimicrobial study of Schefflera vinosa leaves crude extracts against rice pathogens. Arabian Journal of Chemistry, 14(7), 103243.
Talib, W. H., Mahmod, A. I., Awajan, D., Hamed, R. A., & Al-Yasari, I. H. (2022). Immunomodulatory, Anticancer, and Antimicrobial Effects of Rice Bran Grown in Iraq: An In Vitro and. Vivo Study Pharmaceuticals, 15(12), 1502. https://doi.org/10.3390/ph15121502
Article CAS PubMed PubMed Central Google Scholar
Wu, J. (2021). The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application. Journal of Personalized Medicine, 11(8), 771. https://doi.org/10.3390/jpm11080771
Article PubMed PubMed Central Google Scholar
Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023). Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of Personalized Medicine, 13(3), 389. https://doi.org/10.3390/jpm13030389
Comments (0)